Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2003 1
2008 1
2009 2
2010 1
2011 2
2012 2
2013 4
2014 5
2015 2
2016 3
2017 3
2018 6
2019 11
2020 9
2021 15
2022 5
2023 5
2024 3
2025 1

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

71 results

Results by year

Filters applied: . Clear all
Page 1
Trial of Prasinezumab in Early-Stage Parkinson's Disease.
Pagano G, Taylor KI, Anzures-Cabrera J, Marchesi M, Simuni T, Marek K, Postuma RB, Pavese N, Stocchi F, Azulay JP, Mollenhauer B, López-Manzanares L, Russell DS, Boyd JT, Nicholas AP, Luquin MR, Hauser RA, Gasser T, Poewe W, Ricci B, Boulay A, Vogt A, Boess FG, Dukart J, D'Urso G, Finch R, Zanigni S, Monnet A, Pross N, Hahn A, Svoboda H, Britschgi M, Lipsmeier F, Volkova-Volkmar E, Lindemann M, Dziadek S, Holiga Š, Rukina D, Kustermann T, Kerchner GA, Fontoura P, Umbricht D, Doody R, Nikolcheva T, Bonni A; PASADENA Investigators; Prasinezumab Study Group. Pagano G, et al. N Engl J Med. 2022 Aug 4;387(5):421-432. doi: 10.1056/NEJMoa2202867. N Engl J Med. 2022. PMID: 35921451 Clinical Trial.
Tuberculous Optochiasmatic Arachnoiditis.
Amado C, Lizárraga KJ. Amado C, et al. Among authors: lizarraga kj. N Engl J Med. 2023 Feb 16;388(7):641. doi: 10.1056/NEJMicm2205437. Epub 2023 Feb 11. N Engl J Med. 2023. PMID: 36779645 No abstract available.
Dengue-associated kidney disease.
Lizarraga KJ, Nayer A. Lizarraga KJ, et al. J Nephropathol. 2014;3(2):57-62. doi: 10.12860/jnp.2014.13. Epub 2013 Dec 28. J Nephropathol. 2014. PMID: 24772398 Free PMC article. Review.
Deep Phenotyping of Parkinson's Disease.
Dorsey ER, Omberg L, Waddell E, Adams JL, Adams R, Ali MR, Amodeo K, Arky A, Augustine EF, Dinesh K, Hoque ME, Glidden AM, Jensen-Roberts S, Kabelac Z, Katabi D, Kieburtz K, Kinel DR, Little MA, Lizarraga KJ, Myers T, Riggare S, Rosero SZ, Saria S, Schifitto G, Schneider RB, Sharma G, Shoulson I, Stevenson EA, Tarolli CG, Luo J, McDermott MP. Dorsey ER, et al. Among authors: lizarraga kj. J Parkinsons Dis. 2020;10(3):855-873. doi: 10.3233/JPD-202006. J Parkinsons Dis. 2020. PMID: 32444562 Free PMC article. Review.
Molecular imaging of movement disorders.
Lizarraga KJ, Gorgulho A, Chen W, De Salles AA. Lizarraga KJ, et al. World J Radiol. 2016 Mar 28;8(3):226-39. doi: 10.4329/wjr.v8.i3.226. World J Radiol. 2016. PMID: 27029029 Free PMC article. Review.
Update on current and emerging therapies for dystonia.
Lizarraga KJ, Al-Shorafat D, Fox S. Lizarraga KJ, et al. Neurodegener Dis Manag. 2019 Jun;9(3):135-147. doi: 10.2217/nmt-2018-0047. Epub 2019 May 22. Neurodegener Dis Manag. 2019. PMID: 31117876 Review.
Unusual gait disorders: a phenomenological approach and classification.
Paramanandam V, Lizarraga KJ, Soh D, Algarni M, Rohani M, Fasano A. Paramanandam V, et al. Among authors: lizarraga kj. Expert Rev Neurother. 2019 Feb;19(2):119-132. doi: 10.1080/14737175.2019.1562337. Epub 2018 Dec 30. Expert Rev Neurother. 2019. PMID: 30585519 Review.
Opsoclonus-myoclonus-encephalopathy induced by cefepime.
Lizarraga KJ, Heros DO, Adams D, Lang AE, Kanner AM. Lizarraga KJ, et al. J Neurol Sci. 2019 Jan 15;396:33-35. doi: 10.1016/j.jns.2018.10.028. Epub 2018 Nov 1. J Neurol Sci. 2019. PMID: 30412900 No abstract available.
71 results